Evexia Lifecare Ltd Stock Hits 52-Week Low Amidst Continued Underperformance

Price Movement and Market Context

On 20 Feb 2026, Evexia Lifecare’s stock price settled at Rs.1.49, representing a steep fall from its 52-week high of Rs.3.04. This decline equates to a loss of approximately 51% from its peak within the last year. Despite the stock’s underperformance, it marginally outperformed its sector today by 0.26%, though it remains well below all key moving averages including the 5-day, 20-day, 50-day, 100-day, and 200-day averages. This persistent weakness contrasts with the broader market’s positive momentum, as the Sensex rebounded sharply by 640.20 points to close at 82,912.69, just 3.92% shy of its own 52-week high of 86,159.02.

Financial Performance and Valuation Metrics

Evexia Lifecare’s financial indicators reveal a challenging environment for the company. Over the last five years, the company’s operating profits have contracted at a compounded annual growth rate (CAGR) of -23.63%, signalling sustained pressure on earnings. The latest quarterly results for December 2025 were largely flat, reflecting a continuation of subdued performance. Profitability metrics remain modest, with an average Return on Equity (ROE) of just 0.88%, indicating limited returns generated on shareholders’ funds.

The company’s ability to service debt is constrained, as evidenced by a Debt to EBITDA ratio of -1.00 times, highlighting a negative EBITDA scenario that complicates leverage management. Return on Capital Employed (ROCE) stands at a low 0.1%, which, while indicating fair valuation with an Enterprise Value to Capital Employed ratio of 0.9, also points to limited efficiency in capital utilisation.

Comparative Performance and Market Position

Evexia Lifecare’s stock has underperformed significantly relative to broader market indices and peers. Over the past year, the stock has delivered a negative return of -44.73%, in stark contrast to the Sensex’s positive 9.48% gain over the same period. This underperformance extends to the BSE500 index, where Evexia has lagged over one year, three months, and three years, reflecting persistent challenges in regaining investor confidence and market traction.

Valuation-wise, the stock trades at a discount compared to the average historical valuations of its peers in the edible oil sector. Despite this discount, the company’s profitability and growth metrics remain subdued, with profits declining by 60.3% over the last year. The majority shareholding remains with non-institutional investors, which may influence liquidity and trading dynamics.

Technical Indicators and Moving Averages

From a technical perspective, Evexia Lifecare is trading below all major moving averages, including the short-term 5-day and 20-day averages as well as the longer-term 50-day, 100-day, and 200-day averages. This positioning suggests a sustained downtrend in price momentum. The stock’s Mojo Score stands at 20.0, with a Mojo Grade of Strong Sell, an upgrade from the previous Sell rating as of 28 Apr 2025, reflecting deteriorated fundamentals and market sentiment.

Sector and Market Environment

The edible oil sector, where Evexia Lifecare operates, has faced a mixed environment with fluctuating commodity prices and competitive pressures. While the broader market, led by mega-cap stocks, has shown strength—evidenced by the Sensex’s 0.5% gain today—the sector’s smaller constituents like Evexia have struggled to keep pace. The Sensex’s 50-day moving average remains above its 200-day moving average, signalling a generally positive market trend, yet Evexia’s stock remains detached from this momentum.

Despite the stock’s recent outperformance relative to its sector by 0.26% on the day of the new low, the prevailing trend remains negative, with the stock’s price trajectory continuing to reflect underlying financial and valuation concerns.

Shareholding and Liquidity Considerations

Evexia Lifecare’s shareholding pattern is dominated by non-institutional investors, which may impact the stock’s liquidity and trading volumes. This ownership structure can influence price stability and market responsiveness, particularly during periods of volatility or sectoral shifts.

Summary of Key Metrics

To summarise, the stock’s key metrics as of 20 Feb 2026 are:

• 52-week low price: Rs.1.49
• 52-week high price: Rs.3.04
• One-year return: -44.73%
• Operating profit CAGR (5 years): -23.63%
• Debt to EBITDA ratio: -1.00 times
• Return on Equity (average): 0.88%
• Return on Capital Employed: 0.1%
• Enterprise Value to Capital Employed: 0.9
• Mojo Score: 20.0 (Strong Sell)
• Market Cap Grade: 4

These figures collectively illustrate the challenges faced by Evexia Lifecare in maintaining growth and profitability, which have been reflected in its stock price performance over the past year.

Conclusion

Evexia Lifecare Ltd’s fall to a new 52-week low of Rs.1.49 highlights the ongoing difficulties the company faces within the edible oil sector. Despite a broader market rally and sectoral movements, the stock’s financial metrics and valuation indicators point to a sustained period of subdued performance. The company’s limited profitability, declining operating profits, and leverage concerns have contributed to its current market standing. While the stock trades at a discount relative to peers, its position below all major moving averages and a Strong Sell Mojo Grade underscore the prevailing cautious outlook.

Limited Period Only. Start at Rs. 9,999 - Get MojoOne for 1 Year + 3 Months FREE (60% Off) Get 71% Off →